First Tracks Biotherapeutics Inc (TRAX) Financials
TRAX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 290.6 million | 33.1 million |
| March 31, 2025 | ? | -391.6 million |
TRAX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -32.6 million | 11.5 million |
| March 31, 2025 | -45.0 million | 7.7 million |
TRAX Net Income
No data available :(
TRAX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 286.5 million | - | - |
| March 31, 2025 | 385.4 million | - | - |
TRAX Shares Outstanding
TRAX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 17000 | 34.0 million | 18.9 million | - |
| March 31, 2025 | 35000 | 41.5 million | 9.8 million | - |
TRAX Cost of Revenue
No data available :(
TRAX
Price: $42.97
52 week price:
Earnings Per Share: -4.66 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.6 billion